ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce

7680697000014 CH-69700 L01FX26 07.16.1.
ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce
ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce
ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce
1 / 3
google

Details

GTIN
7680697000014
Pharmacode
-
Product number
6970001
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
mirvetuximabum soravtansinum 100 mg, acidum aceticum, polysorbatum 20, natrii acetas corresp. natrium 2.94 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 20 ml.

Articles (1)

ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/06/2026
Professional SmPC
Français
16/06/2026
Professional SmPC
Italien
16/06/2026

Detailed composition

Substance Quantity Type Category
mirvetuximabum soravtansinum
100.0 MG Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
natrii acetas
- Substance HNIDK
natrium
2.94 MG Substance HBESI
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 3394.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2026

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69700
Drug name
ELAHERE, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FX26
Authorization status
Z
Dispensation category
A
First authorization
13/03/2025
Authorization expiration date
12/03/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Ovarial-, Tuben- oder primäres Peritonealkarzinom

Packaging details

Description (FR)
ELAHERE 100 mg/20 ml conc perf 100 mg 1 pce
Description (DE)
ELAHERE 100 mg/20 ml Konz Inf 100 mg 1 Stk
Market launch
13/03/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data